Envista Q4 sales up 5.8% to $651.8M; guides FY22 core growth 6-8%, adj EBITDA margin >20%

Envista Holdings Corp

2021-FY EPS reported $1.92 revenue$2,508,900,000

Q4 net income $42.5M ($0.24 diluted EPS); adjusted EPS $0.46 vs $0.43 in Q4 2020.
Full-year 2021 core sales growth 29%; Q4 core sales growth 6.6% on $651.8M revenue.
2022 guidance: core growth 6-8%, adjusted EBITDA margin >20%, barring significant COVID disruptions.
Pending acquisition of Carestream Dental's IOS business expected to close in Q2 2022; excluded from guidance.
Completed sale of KaVo Treatment Unit and Instrument business on Dec 31, 2021; results reflect continuing operations.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.